Dr.Zhen Cao, Pharmaceutical Policy and Regulation ,Best Researcher Award

Dr.Zhen Cao, at School of Public Health, Capital Medical University,China

Author Profile

Academic and Professional Background 🌟

Cao Zhen is a dedicated doctoral candidate at the School of Public Health, Capital Medical University, specializing in health policy and hospital management. With a robust academic foundation, Cao Zhen is a valued member of the Expert Pool for Project Funding Supervision at the National Health Commission. Her impressive track record includes overseeing two provincial and ministerial-level projects, participation in a National Social Science Foundation project, and contributing to numerous other provincial and ministerial-level initiatives. Her scholarly contributions are evidenced by the publication of nine academic papers in reputable journals.

 


Research and Innovations 🔬📊

  • Completed/Ongoing Research Projects: 15
  • Consultancy/Industry Projects: 2
  • Journals Published (SCI, Scopus, etc.): 9
  • Patents Published/Under Process: 2
  • Collaborations: Notably collaborated with the National Health Commission of the People’s Republic of China during the COVID-19 pandemic to study funding and material support for epidemic prevention and control, as well as the economic operation of hospitals. This collaboration provided crucial decision-making support to tackle pandemic-related challenges.

Professional Memberships 🏅

  • People’s Republic of China Health and Wellness Commission
  • Project Funding Supervision Expert Pool

Research Areas 🔍

  • Hospital Management
  • Health Policy

 

🎓Publication Top Noted:

Paper Title :Adenylyl cyclase localization to the uropod of aggregating Dictyostelium cells requires RacC
    • Authors: Sherly I Celada, Guoliang Li, Lindsay J Celada, Wenfu Lu, Thanigaivelan Kanagasabai, Weiran Feng, Zhen Cao, Nazifa Salsabeel, Ninghui Mao, LaKendria K Brown, Zaniya A Mark, Michael G Izban, Billy R Ballard, Xinchun Zhou, Samuel E Adunyah, Robert J Matusik, Xiaofei Wang, Zhenbang Chen
    • Journal: Molecular Oncology
    • Year:2023
    • Citations : 3

     

Paper Title :Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
  • Authors: Thomas Wiesner, William Lee, Anna C Obenauf, Leili Ran, Rajmohan Murali, Qi Fan Zhang, Elissa WP Wong, Wenhuo Hu, Sasinya N Scott, Ronak H Shah, Iñigo Landa, Julia Button, Nathalie Lailler, Andrea Sboner, Dong Gao, Devan A Murphy, Zhen Cao, Shipra Shukla, Travis J Hollmann, Lu Wang, Laetitia Borsu, Taha Merghoub, Gary K Schwartz, Michael A Postow, Charlotte E Ariyan, James A Fagin, Deyou Zheng, Marc Ladanyi, Klaus J Busam, Michael F Berger, Yu Chen, Ping Chi
  • Journal: Nature
  • Year:2015
  • Citations : 240
Paper Title : Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth
  • Authors: Leili Ran, Inna Sirota, Zhen Cao, Devan Murphy, Yuedan Chen, Shipra Shukla, Yuanyuan Xie, Michael C Kaufmann, Dong Gao, Sinan Zhu, Ferdinando Rossi, John Wongvipat, Takahiro Taguchi, William D Tap, Ingo K Mellinghoff, Peter Besmer, Cristina R Antonescu, Yu Chen, Ping Chi
  • Journal: Cancer discovery
  • Year:2015
  • Citations :130
Paper Title :SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
  • Authors:Ping Mu, Zeda Zhang, Matteo Benelli, Wouter R Karthaus, Elizabeth Hoover, Chi-Chao Chen, John Wongvipat, Sheng-Yu Ku, Dong Gao, Zhen Cao, Neel Shah, Elizabeth J Adams, Wassim Abida, Philip A Watson, Davide Prandi, Chun-Hao Huang, Elisa De Stanchina, Scott W Lowe, Leigh Ellis, Himisha Beltran, Mark A Rubin, David W Goodrich, Francesca Demichelis, Charles L Sawyers
  • Journal:Science
  • Year: 2017
  • Citations :905
Paper Title : Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation
  • Authors: Zeda Zhang, Chuanli Zhou, Xiaoling Li, Spencer D Barnes, Su Deng, Elizabeth Hoover, Chi-Chao Chen, Young Sun Lee, Yanxiao Zhang, Choushi Wang, Lauren A Metang, Chao Wu, Carla Rodriguez Tirado, Nickolas A Johnson, John Wongvipat, Kristina Navrazhina, Zhen Cao, Danielle Choi, Chun-Hao Huang, Eliot Linton, Xiaoping Chen, Yupu Liang, Christopher E Mason, Elisa de Stanchina, Wassim Abida, Amaia Lujambio, Sheng Li, Scott W Lowe, Joshua T Mendell, Venkat S Malladi, Charles L Sawyers, Ping Mu
  • Journal: Cancer cell
  • Year: 2020
  • Citations : 114
Dr.Zhen Cao, Pharmaceutical Policy and Regulation ,Best Researcher Award

You May Also Like